The Valley Desk

NCT04888585 · Interventional trial

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)

Overall registry status Terminated

Phase 2

Conditions Rheumatoid Arthritis (RA)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov